Calliditas Therapeutics AB (CALT)
20.00
+1.00
(+5.25%)
USD |
NASDAQ |
May 03, 16:00
Calliditas Therapeutics Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | -0.5129M |
| September 30, 2022 | -0.9943M |
| June 30, 2022 | -0.8963M |
| March 31, 2022 | -3.105M |
| December 31, 2021 | -2.844M |
| September 30, 2021 | -21.05M |
| June 30, 2021 | -21.09M |
| March 31, 2021 | -18.88M |
| December 31, 2020 | -18.85M |
| September 30, 2020 | -0.0583M |
| June 30, 2020 | -1.701M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.913M |
| December 31, 2019 | -1.913M |
| September 30, 2019 | -1.855M |
| June 30, 2019 | -0.2124M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -0.0059M |
| June 30, 2018 | -0.0059M |
| March 31, 2018 | -0.0059M |
| December 31, 2017 | -0.0059M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-21.09M
Minimum
Jun 2021
-0.0583M
Maximum
Sep 2020
-6.392M
Average
-1.913M
Median
Dec 2019
Cash from Investing (TTM) Benchmarks
| DBV Technologies SA | -0.808M |
| Cellectis SA | -15.51M |
| Adaptimmune Therapeutics PLC | 176.54M |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals Plc | -0.3289M |